At the request of parents undergoing In Vitro Fertilization (IVF), gender selection is accomplished through a medical technology known as Preimplantation Genetic Screening (PGS/NGS). The PGS process takes place in conjunction with a fresh IVF cycle by an experienced embryologist while the embryos are developing in vitro. After several days of embryo development in vitro, all embryos undergo PGS to determine each embryo’s gender before transfer to the woman’s uterus for implantation into her uterine lining.
Family balancing is available to New Hope Fertility NYC patients through PGS in conjunction with IVF because gender identification of embryos is an inevitable by-product of the technology. Gender selection through PGS allows parents to select the sex of their child with more than 99 percent accuracy.
When multiple quality embryos are gender identified, parents-to-be have the ability to select the sex of their baby. Only one or two quality embryos of the desired sex is transferred during a fresh IVF cycle to avoid a multiple pregnancy. Excess embryos can be cryopreserved for future Frozen Embryo Transfers (FETs). Parents have the ability to choose the gender of their future babies – an optimum method of family planning.
Through PGS, testing can be performed on embryos developing in vitro to detect abnormalities that could risk a healthy pregnancy. PGS searches for aneuploidy – extra or missing chromosomes. These low quality embryos will be screened out.
PGS is a phenomenal technology used to detect:
Contact Dr. John Zhang if you interested in gender selection in conjunction with IVF to plan your family. It is important to work with a fertility specialist who is accomplished in PGS technology.
To schedule your one-on-one initial consultation with Dr. John Zhang – call 917.525.5496.